Abiraterone Tablet Manufacturer, Exporter and Global Supplier

Abiraterone Tablet Manufacturer, as a reputed we deliver a clinically proven oncology formulation used for the treatment of advanced and metastatic prostate cancer. Abiraterone Acetate, the active ingredient in the tablet, is a powerful androgen biosynthesis inhibitor that works by reducing the production of testosterone—the hormone responsible for promoting prostate cancer cell growth. Our Abiraterone Tablet is developed under stringent WHO-GMP and ISO-certified manufacturing conditions to ensure consistent quality, safety, and therapeutic effectiveness for patients worldwide.

Product Overview

Each Abiraterone Tablet contains Abiraterone Acetate, a highly selective inhibitor of the enzyme CYP17A1, which plays a crucial role in androgen synthesis within the testes, adrenal glands, and prostate tumor tissues. By blocking this enzyme, the tablet effectively lowers androgen levels, helping slow or halt the progression of prostate cancer.

As a globally trusted Abiraterone Tablet Manufacturer, we ensure that every tablet is produced using state-of-the-art technology and undergoes rigorous quality control testing to meet international pharmacopeial standards. Our production facilities are equipped with advanced analytical instruments and clean-room environments to maintain sterility, precision, and potency across every batch.

Uses of Abiraterone Tablet

Abiraterone Tablet is widely prescribed for:

• Metastatic Castration-Resistant Prostate Cancer (mCRPC) in adult men.

• Metastatic High-Risk Castration-Sensitive Prostate Cancer (mCSPC) when combined with corticosteroids like prednisone or prednisolone.

• Hormonal therapy regimens where testosterone suppression is crucial to managing tumor growth.

This medicine is usually administered alongside corticosteroids to help minimize treatment-related side effects and optimize hormonal balance. As a responsible Abiraterone Tablet Manufacturer, we ensure precise dosage uniformity and pharmacological performance that healthcare professionals can trust.

Precautions

Patients receiving Abiraterone Tablet should follow the below precautions for safe and effective therapy:

• The medication should be taken on an empty stomach, at least two hours before or one hour after meals.

• It must always be used with corticosteroids to prevent mineralocorticoid excess, which can cause high blood pressure or fluid retention.

• Regular monitoring of liver function, potassium levels, and blood pressure is essential during treatment.

• The medicine is not intended for use in women or children and should be handled with care by healthcare professionals.

• Patients with liver or heart disease must inform their doctor before beginning therapy.

• Avoid consuming alcohol or high-fat meals, as they can alter drug absorption.

Our role as an ethical Abiraterone Tablet Manufacturer involves providing clear labeling, dosage instructions, and comprehensive safety information to ensure proper usage across global markets.

Side Effects

Like all potent oncology medications, Abiraterone Tablet may cause some side effects. The most frequently reported include:

• Fatigue, headache, or dizziness

• Fluid retention or swelling in ankles

• Hypertension (elevated blood pressure)

• Low potassium levels (hypokalemia)

• Increased liver enzymes

• Joint or muscle pain

Most adverse effects are mild and manageable with regular medical supervision. However, patients should contact their physician immediately if they experience severe reactions or persistent discomfort.

Why Choose Us as Your Abiraterone Tablet Manufacturer

As a leading Abiraterone Tablet Manufacturer, we combine pharmaceutical innovation with stringent quality assurance to provide oncology solutions that meet the evolving needs of healthcare providers and patients. Our manufacturing units are WHO-GMP, ISO, and FDA-compliant, guaranteeing reliability, purity, and consistency. We also provide complete documentation, global export assistance, and customizable packaging to meet diverse market requirements.

Key highlights of our manufacturing excellence include:

• WHO-GMP & ISO-certified production infrastructure

• Strict adherence to pharmacovigilance and regulatory norms

• Advanced formulation technology ensuring optimum bioavailability

• Timely global supply and competitive pricing

Our Abiraterone Tablet is distributed to leading hospitals, oncology centers, and pharmaceutical distributors worldwide, reinforcing our reputation as a dependable partner in cancer care.

Conclusion

Abiraterone Tablet represents a breakthrough in prostate cancer treatment, offering proven hormonal control and improved patient outcomes. With world-class facilities, stringent quality measures, and unwavering commitment to global health standards, we stand as a distinguished Abiraterone Tablet Manufacturer dedicated to advancing cancer therapy and patient well-being through innovation, quality, and trust.

Global Distribution Network

With a strong logistics and compliance framework, we successfully export Abiraterone Tablet to a broad range of international markets, including: Venezuela, Brazil, Cambodia, Philippines, Nigeria, Myanmar, Thailand, Singapore, Russia, Kyrgyzstan, Tajikistan, Kenya, Zimbabwe, Somalia, Djibouti, Belarus, Macedonian, And Turkey.